HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)
Forecasted Federal grant Posted
- Opportunity number
- PAS-28-073
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications expected due
- Award size
- Not on record
Opportunity facts
- Expected posting
- Assistance listings
-
- 93.273 Alcohol Research Programs
- Funding instrument
- Grant
- Category
-
- Health
- Eligible applicants
-
- State Governments
- Higher Education Inst. (Public)
- Tribal Organizations (Not Federally Recognized)
- Other
- Small Businesses
- For Profit Organizations
- 501(c)(3) Nonprofits
- City/Township Governments
- Tribal Governments (Federally Recognized)
- Higher Education Inst. (Private)
- Public or Indian Housing Auth.
- Special District Governments
- Non-501(c)(3) Nonprofits
- Independent School Districts
- County Governments
- Points of contact
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Institutes of Health is forecasting a Notice of Funding Opportunity using a R61/R33 Phased Innovation Award to support HIV prevention research that advances from development and feasibility testing to larger-scale efficacy and effectiveness studies, with no stated application deadline provided in this forecast notice.
Eligible applicants include state governments, higher education institutions (public and private), tribal organizations (federally and non-federally recognized), small businesses, for-profit and nonprofit organizations, city and county governments, public housing authorities, special district governments, independent school districts, eligible federal agencies, U.S. territories and possessions, and faith-based or community-based organizations.
The R61 phase supports development, refinement, adaptation, and pilot testing of novel or enhanced HIV prevention and treatment strategies, including studies addressing key scientific, operational, or implementation questions necessary to establish feasibility and readiness for larger-scale evaluation. Projects may generate evidence to optimize intervention design, delivery, and implementation in diverse populations and settings. The R33 phase supports expanded testing of interventions and implementation strategies that have successfully met R61 milestones, evaluating effectiveness, implementation, scalability, sustainability, clinical management, or delivery of HIV prevention interventions that include integrated approaches addressing alcohol use and related comorbidities.
This opportunity is assigned under Assistance Listing 93.273 (Alcohol Research Programs), administered by the National Institute on Alcohol Abuse and Alcoholism within the National Institutes of Health. The program funds research across biomedical, genetic, psychological, behavioral, environmental, and health services domains related to alcohol abuse, alcoholism prevention, treatment, and related health effects. Applications are evaluated on scientific and technical merit, program balance, and relevance to NIAAA priorities and public health issues. Research must be performed in the United States and its possessions.
Forecast synopsis
This Notice of Funding Opportunity (NOFO) uses a R61/R33 Phased Innovation Award to support milestone-driven research that advances innovative HIV prevention interventions from development and feasibility testing to larger-scale efficacy, effectiveness, implementation, and dissemination studies. The R61 phase will support the development, refinement, adaptation, and pilot testing of novel or enhanced HIV prevention and treatment strategies, including studies designed to address key scientific, operational, or implementation questions necessary to establish feasibility and readiness for larger-scale evaluation. Projects may generate evidence needed to optimize intervention design, delivery, and implementation in diverse populations and settings. The R33 phase will support expanded testing of interventions and implementation strategies that have successfully met R61 milestones. Studies may evaluate effectiveness, implementation, scalability, sustainability, clinical management, or delivery of HIV prevention interventions that include integrated approaches addressing alcohol use and related comorbidities.
Eligibility
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity